Acadia Healthcare Inc Revenue Growth Rates (ACHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Acadia Healthcare Company Inc   (NASDAQ: ACHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ACHC's Revenue Growth by Quarter and Year

Acadia Healthcare Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 828.80
FY 828.80

ACHCs Annual Revenue
Acadia Healthcare Inc 's Revenue in the fiscal year 2025 $ 3,312.77 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2024 $ 3,153.96 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2023 $ 2,928.74 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2022 $ 2,725.62 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2021 $ 2,454.56 millions




ACHC Revenue first quarter 2026 Y/Y Growth Comment
Acadia Healthcare Company Inc reported Revenue growth of 7.57% year on year in the first quarter 2026, to $ 828.80 millions, this is lower than Acadia Healthcare Company Inc 's recent average Revenue surge of 129.6%.

Looking into first quarter 2026 results within Healthcare Facilities industry 18 other companies have achieved higher Revenue growth. While Acadia Healthcare Company Inc ' s Revenue increase of 7.57% ranks overall at the positon no. 1526 in the first quarter 2026.


ACHC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 6.1 % 8.84 % 0.71 %
3rd Quarter September - 4.41 % 8.7 % 7.8 %
2nd Quarter June - 9.19 % 8.85 % 7.63 %
1st Quarter March 7.57 % 0.32 % 4.4 % 14.29 %
FY   - 5.04 % 7.69 % -

Financial Statements
Acadia Healthcare Inc 's first quarter 2026 Revenue $ 828.80 millions ACHC's Income Statement
Acadia Healthcare Inc 's first quarter 2025 Revenue $ 770.51 millions Quarterly ACHC's Income Statement


ACHC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -3.54 % -5.07 % -5.19 %
3rd Quarter September - -2.03 % 2.46 % 2.6 %
2nd Quarter June - 12.81 % 3.64 % -0.59 %
1st Quarter March 0.89 % -0.48 % 7.97 % 4.15 %
FY (Year on Year)   - 5.04 % 7.69 % -


Back to ACHC Growth rate Comparisons >> Back to ACHC Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #201
Overall #1526

Revenue Y/Y Growth Statistics
High Average Low
3793.83 % 129.6 % -309 %
(Dec 31 2018)   (March 31, 2015)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #201
Overall #1526
Revenue Y/Y Growth Statistics
High Average Low
3793.83 % 129.6 % -309 %
(Dec 31 2018)   (March 31, 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Acadia Healthcare Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3315.3 % 147.3 % -100 %
(Jun 30 2018)  


ACHC's I. Quarter Q/Q Revenue Comment
Acadia Healthcare Company Inc achieved in the I. Quarter 2026 below company average Revenue growth of 0.89% quarter on quarter, to $ 828.80 millions.

Although the I. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the I. Quarter surge, eclipses the -0.48% growth in the I. Quarter a year ago

Within Healthcare Facilities industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Acadia Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 1506.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #20
Healthcare Sector #198
Overall #1506
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #20
Healthcare Sector #198
Overall #1506
Revenue Q/Q Growth Statistics
High Average Low
3315.3 % 147.3 % -100 %
(Jun 30 2018)  


ACHC's I. Quarter Q/Q Revenue Comment
Acadia Healthcare Company Inc achieved in the I. Quarter 2026 below company average Revenue growth of 0.89% quarter on quarter, to $ 828.80 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.48% in the I. Quarter a year ago.

Within Healthcare Facilities industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Acadia Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 1506.


Acadia Healthcare Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 3,371.07 $ 3,312.77 $ 3,265.55 $ 3,229.61 $ 3,156.42
Y / Y Revenue Growth (TTM) 6.8 % 5.04 % 5.64 % 6.74 % 6.6 %
Year on Year Revenue Growth Overall Ranking # 1777 # 1150 # 1597 # 1405 # 1272
Seqeuential Revenue Change (TTM) 1.76 % 1.45 % 1.11 % 2.32 % 0.08 %
Seq. Revenue Growth (TTM) Overall Ranking # 2451 # 1671 # 1980 # 1769 # 1623


Cumulative Revenue growth Comment
Although Acadia Healthcare Inc 's Annual Revenue growth year on year were below company's average 129.6% , Revenue announced in the Mar 31 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.8% year on year, from 5.04% in Dec 31 2025.

In the Healthcare sector 281 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1150 to 1777.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 282
Overall # 1777

Revenue TTM Y/Y Growth Statistics
High Average Low
3793.83 %
 129.6 %
-309 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 358
S&P 500 # 2451
Cumulative Revenue growth Comment
Although Acadia Healthcare Inc 's Annual Revenue growth year on year were below company's average 129.6% , Revenue announced in the Mar 31 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.8% year on year, from 5.04% in Dec 31 2025.

In the Healthcare sector 281 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1150 to 1777.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 282
Overall # 1777

Revenue TTM Y/Y Growth Statistics
High Average Low
3793.83 %
129.6 %
-309 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 358
S&P 500 # 2451




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACHC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Anika Therapeutics Inc 12.91%$ 12.912 millions
Qhslab Inc 12.90%$ 12.901 millions
Cvrx inc 12.74%$ 12.744 millions
Iradimed Corporation12.65%$ 12.651 millions
Dbv Technologies S a 12.50%$ 12.500 millions
Abbvie Inc 12.43%$ 12.433 millions
Novocure Limited12.30%$ 12.298 millions
Lemaitre Vascular Inc 11.74%$ 11.740 millions
Bausch Health Companies Inc 11.73%$ 11.731 millions
Orthopediatrics Corp11.73%$ 11.726 millions
Innoviva Inc 11.71%$ 11.705 millions
Boston Scientific Corporation11.60%$ 11.602 millions
Keenova Therapeutics Plc11.36%$ 11.360 millions
Aclarion Inc 11.32%$ 11.316 millions
Si bone inc 11.24%$ 11.241 millions
Pacs Group Inc 11.22%$ 11.224 millions
Sight Sciences Inc 11.02%$ 11.021 millions
Ss Innovations International Inc11.01%$ 11.010 millions
Royalty Pharma Plc10.97%$ 10.969 millions
Resmed Inc 10.87%$ 10.875 millions
Medline Inc 10.66%$ 10.656 millions
Rigel Pharmaceuticals Inc10.28%$ 10.284 millions
Msa Safety Inc10.27%$ 10.273 millions
Phibro Animal Health Corporation10.10%$ 10.101 millions
Johnson and Johnson9.91%$ 9.907 millions
Acadia Pharmaceuticals Inc 9.72%$ 9.719 millions
Sotera Health Company9.68%$ 9.683 millions
Universal Health Services Inc 9.65%$ 9.646 millions
Earth Science Tech Inc 9.46%$ 9.462 millions
Bausch and Lomb Corp9.41%$ 9.411 millions


About Acadia Healthcare Inc Revenue Growth Rates (ACHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Acadia Healthcare Company Inc (CIK 1520697).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-321076
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Acadia Healthcare Company Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.